Capital World Investors »

Eikon Therapeutics shares owned by Capital World Investors

Quarter-by-quarter ownership of Eikon Therapeutics shares owned by Capital World Investors from 13F filings

Historical chart of Capital World Investors investment in Eikon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eikon Therapeutics held by Capital World Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eikon Therapeutics by Capital World Investors

Quarter filed Position value Share count Share price at filing
2026-03-31 $12M 1.1M 10.58

More positions owned by Capital World Investors

Broadcom (AVGO)
Meta Platforms Cl A (META)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Philip Morris International (PM)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Micron Technology (MU)
Alphabet Cap Stk Cl C (GOOG)
Vertex Pharmaceuticals Incorporated (VRTX)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Amazon (AMZN)
Amgen (AMGN)
Canadian Natural Resources (CNQ)

View all positions for Capital World Investors

Top funds holding Eikon Therapeutics

BlackRock
Foresite Capital Management IV
Merck & Co
Foresite Capital Management V
Capital World Investors
Alliancebernstein
Vanguard Capital Management
EcoR1 Capital
Baker Bros. Advisors
Soros Capital Management
StepStone
Canada Pension Plan Investment Board
Franklin Resources
Citadel Advisors
General Catalyst Group Management

View all funds holding Eikon Therapeutics